Top
Main
 
All Outcomes
 
Feedback
Home
c19early.org COVID-19 treatment researchSleepSleep (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

Loading...
More

Supplementary Data — Sleep for COVID-19: real-time meta analysis of 15 studies

@CovidAnalysis, July 2024, Version 18V18
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Cloosterman 32% 0.68 [0.43-1.07] symp. case 31/201 222/2,385 Improvement, RR [CI] Treatment Control Gao 36% 0.64 [0.42-0.97] cases case control Kim 17% 0.83 [0.70-0.99] m/s case 2,884 (all patients) Kim 11% 0.89 [0.81-0.97] cases 2,884 (all patients) COVIDENCE UK Holt 12% 0.88 [0.61-1.27] cases 15,227 (all patients) COVIDENCE UK Holt 12% 0.88 [0.68-1.14] cases 15,227 (all patients) COVIDENCE UK Holt 22% 0.78 [0.60-0.99] cases 15,227 (all patients) Marcus 16% 0.84 [0.76-0.93] symp. case 14,335 (all patients) Li 43% 0.57 [0.35-0.90] death 46,535 (all patients) Li 36% 0.64 [0.46-0.89] hosp. 46,535 (all patients) Li 21% 0.79 [0.64-0.96] hosp. 46,535 (all patients) Ahmadi 3% 0.97 [0.59-1.61] death 189/252,788 17/14,520 Mohsin 38% 0.62 [0.49-0.77] severe case 327/948 273/552 Huang 81% 0.19 [0.05-0.66] severe case 12/127 4/9 Paul 67% 0.33 [0.19-0.55] PASC 1,811 (all patients) LONG COVID Paul 54% 0.46 [0.28-0.74] PASC 1,811 (all patients) LONG COVID Jones 39% 0.61 [0.45-0.82] death n/a n/a Jones 32% 0.68 [0.56-0.82] hosp. n/a n/a Jones 7% 0.93 [0.86-1.00] cases n/a n/a Pływaczewska-J.. 17% 0.83 [0.68-1.01] m/s case 1,225 (n) 622 (n) Pływaczewska-J.. 7% 0.93 [0.73-1.16] PASC 1,015 (n) 502 (n) Wang 36% 0.64 [0.50-0.82] PASC 559 (n) 180 (n) LONG COVID Wang 18% 0.82 [0.69-0.99] PASC 1,979 (all patients) LONG COVID Wang 30% 0.70 [0.52-0.94] PASC 238 (n) 166 (n) LONG COVID Pavlidou 40% 0.60 [0.50-0.75] cases 3,345 (n) 1,852 (n) Wang 19% 0.81 [0.72-0.92] death 50,777 (n) 18,119 (n) Wang 15% 0.85 [0.80-0.89] hosp. 50,777 (n) 18,119 (n) Wang 23% 0.77 [0.73-0.82] PASC 50,777 (n) 18,119 (n) Sleep COVID-19 outcomes c19early.org July 2024 Favors good sleep Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit